Lv31
330 积分 2021-04-29 加入
Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies
12小时前
已完结
Identification of chromosomal instability-associated genes as hepatocellular carcinoma progression-related biomarkers to guide clinical diagnosis, prognosis and therapy
12小时前
已完结
Aneuploidy in Hepatocellular Carcinoma: Risk Factors, Mechanisms, and Clinical Relevance
13小时前
已完结
Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity
1个月前
已完结
RIPPLY1 suppresses cancer cell stemness via targeting TBX19 in CTNNB1-mutated hepatocellular carcinoma
1个月前
已完结
Chronic kidney disease
1个月前
已完结
515LBA (PB-515) LBA Posters: CID-078, a first-in-class oral macrocycle cyclin A/B-RxL inhibitor, demonstrates anti-tumor activity in E2F-driven cancers
1个月前
已完结
CELL CYCLE DYSREGULATION IN CANCER
1个月前
已完结
Enhanced SLC35B2/SAV1 sulfation axis promotes tumor growth by inhibiting Hippo signaling in HCC
3个月前
已完结
CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade
3个月前
已完结
皖公网安备34019202002308
